1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) 10-11 September,

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Regional Situation on ICD Implementation and Related Activities in the South East Asia Region of WHO Jyotsna Chikersal RA-HST, WHO-SEARO WHO-FIC APN Meeting,
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
TRCS EXPERIENCE ON SOCIAL MOBILIZATION FOR INTEGRATED MEASLES CAMPAIGN OF 2011 TANZANIA RED CROSS SOCIETY MEASLES & RUBELLA INITIATIVE MEETING WASHINGTON.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
World Health Organization
Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Country Report Progress Toward Strengthening EPI [Country Name]
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
Global burden of LF Around 1.4 billion people in 73 countries at risk Over 120 million infected About 40 million disfigured and incapacitated.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University.
Measles and Measles Outbreaks in China Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting Geneva, Switzerland June 19,
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
Malaria Elimination in South East Asia Region Progress, Challenges and the Way Forward Dr. Deyer Gopinath, WHO / Thailand Dr. Leonard Ortega, WHO / SEARO.
GAVI’S NEW MEASLES AND RUBELLA STRATEGY Dr. Khin Devi Aung Gavi Secretariat 21 June 2016, Geneva 1 #vaccineswork.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
World Health Organization
Regional WHO Measles and Rubella Focal Point Meeting
Innovations: Measles Programmatic Risk Assessments
Global Overview of Measles
World Health Organization
Measles Containing Vaccines
Measles & Rubella Initiative Partners meeting September 7-8, 2017
World Health Organization
Session 1: New Opportunities and New Direction
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Stakeholder Consultation
African Region- priorities to reach the 2020 measles elimination goal.
Experience with the measles outbreak response fund
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
Presentation transcript:

1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September, Washington DC

2 2 Progress in immunization against Measles and rubella, SEA Region, 2000 to 2012 Coverage with 1 st dose measles vaccine increased from 61% to 79%; 6 countries with 1 st dose coverage >95% 10 countries introduced 2 nd routine dose of measles vaccine 10 countries have conducted wide age-range measles supplemental immunization campaigns; 8 have conducted follow-up measles immunization campaigns 7 countries use rubella vaccination in combination with measles and or mumps vaccine Wide age range campaigns with Measles and rubella vaccine in Nepal in 2012; Bangladesh in 2013 India achievements in the past two years  2 nd routine dose of measles immunization in 21 States  Campaigns in 14 States – 139 million children aged 6 months to 10 years

3 3 Impact on measles burden SEA Region, 2000 to % decrease in measles cases 70% decline in measles deaths by 2011 in all Member States except India (48% overall) 63% decline in measles incidence rate from 69.9 per million population to 25.0 per million Bhutan, DPR Korea, Maldives and Sri Lanka may have eliminated measles (and rubella in Sri Lanka) Improved knowledge of circulating measles and rubella genotypes

4 4 MCV1 Coverage for SEAR countries,

5 5 Setting the stage for measles elimination and rubella/CRS control in SEA Region At the meeting of the SEA Regional Committee this week, a resolution is being considered for adoption setting 2020 as the target year for the elimination of measles and rubella/CRS control in the WHO South-East Asia Region A detailed strategic plan with costing is already developed A measles surveillance workshop will be held from September to strengthen country measles/rubella/CRS surveillance in preparation towards the achievement of the goal of measles elimination and rubella/CRS control in SEAR by 2020 A massive measles campaign, targeting more than 52 million 9 months to 15 years of age children is to start in Bangladesh from 2 November 2013 An integrated polio/measles surveillance started statewide for UP in India, possibly the largest such surveillance activity

6 6 Key challenges Securing and maintaining political commitment  Success in polio; "Can do" spirit  Regional Committee’s engagement  Commitment to intensification of routine immunization  Solidarity with other Regions Ensuring adequate funding (Approx. USD780 millions excluding additional cost of increasing RI coverage >95%)  National financing important  External funding necessary Making available adequate vaccine supply Establishing case based surveillance for measles/rubella Applying the lessons learned from polio  Reaching the unreached Large countries – herd immunity; scale of operations

7 7 THANK YOU